Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1017445

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Zoledronic Acid
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that there is equality geographically in the availability of Zoledronic acid for breast cancer treatment.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	197655
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>Decisions on the routine availability of medicines, such as Zoledronic acid, are made locally by clinical commissioning groups (CCGs). CCGs make funding decisions based on the needs of their population. Commissioning is about getting the best possible health outcomes for the local population and this involves assessing local needs to inform priorities and strategies.</p><p> </p><p>Under their terms of service, clinicians are allowed to prescribe any product which they consider to be a medicine necessary for the treatment of their patients under the National Health Service, subject to two provisos: firstly, that the product is not included in Schedules 1 or 2 to the NHS (General Medical Services Contracts)(Prescription of Drugs etc.) Regulations 2004 and secondly, that the clinician is prepared to justify any challenges to their prescribing by their local CCG.</p><p> </p><p>Decisions on whether to routinely fund medicines should be taken in the context of the CCGs available resources to ensure that care is fairly allocated to all patients and, where appropriate, measured against the CCGs other service development priorities.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:47:52 answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper

1017449

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has plans for blood glucose testing strips and needles to remain available by prescription.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	197624
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>This is a matter for NHS England, working in partnership with NHS Clinical Commissioners to support clinical commissioning groups to use their prescribing resources effectively in the interests of their local population.</p><p> </p><p>NHS England has launched a public consultation on proposals to update and review commissioning guidance on eight products, which includes blood glucose testing strips for type 2 diabetes and needles for pre-filled and re-useable insulin pens. The consultation runs from 28 November 2018 until 28 February 2019. Details of how to respond and attend the public consultation events can be found at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:40:09 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

1017458

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes and Obesity
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he last met the National Clinical Directors for Obesity and Diabetes for NHS England.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	197588
answer	answer is ministerial correction date of answer 07/12/2018 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care, has not had any meetings with the National Clinical Director for Obesity and Diabetes for NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2018 12:55:07 answering member 4067 label Biography information for Steve Brine
tabling member	338 label Biography information for Keith Vaz

1017491

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of the introduction of a target for patients with pancreatic cancer to receive treatment within 20 days of diagnosis.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	197646
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>The Prime Minister announced the Government’s ambitions to see 55,000 more people surviving cancer for five years in England each year from 2028 and three quarters of all cancers detected at an early stage by 2028. To achieve these targets, we will need to make significant progress on survival across all cancers, including pancreatic cancer. NHS England will shortly be introducing a Faster Diagnostic Standard of 28 days for all cancer patients which, when taken together with the 62-day referral to treatment standard, will mean that all patients should expect to start their treatment within 34 days of diagnosis. This is a maximum, and trusts should continue to treat patients more quickly particularly where there is a strong clinical need.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:46:57 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

1017502

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of (a) leukaemia, (b) non-Hodgkin lymphoma, (c) Hodgkin lymphoma and (d) myeloma cases were diagnosed at each cancer stage in each of the last five years.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	197620
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>This information is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/12/2018 15:38:39 answering member 4067 label Biography information for Steve Brine
tabling member	3960 label Biography information for Henry Smith

1017522

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the progress report for 2017-18 on Achieving world-class cancer outcomes: a strategy for England.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	197606
answer	answer is ministerial correction date of answer 07/12/2018 answer text <p>NHS England is currently working on the third progress report into the delivery of the five-year cancer strategy for England. While reporting on the progress that has been made, the report will also look to the future and the fit between the cancer strategy and the long-term plan for the National Health Service. The report will be published in due course.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2018 12:56:28 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson